MiniMed Group, Inc. (MMED)
18.80
+0.81
(+4.50%)
USD |
NASDAQ |
Nov 16, 11:23
MiniMed Group Gross Profit Margin (Quarterly) : 55.04% for July 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 55.04% |
| April 30, 2026 | 57.59% |
| January 31, 2026 | 58.61% |
| Date | Value |
|---|---|
| July 31, 2025 | 57.95% |
| April 30, 2025 | 57.04% |
| January 31, 2025 | 58.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 50.36% |
| Baxter International, Inc. | 33.30% |
| Becton, Dickinson & Co. | 51.06% |
| Boston Scientific Corp. | 62.20% |
| Insulet Corp. | 75.51% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.84% |
| Return on Assets | -6.93% |
| Return on Invested Capital | -8.69% |
| Operating Margin (Quarterly) | 7.71% |
| Return on Net Operating Assets | -7.88% |